Taipei, June 2016. Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Introduction India has the highest burden of tuberculosis in the world, with an estimated 2 million cases annually, accounting for 1/5 th of global incidence.
1 [INSERT COUNTRY NAME HERE] Introduction to the National MDR-TB Control Strategy SESSION 1 Insert country/ministry logo here.
Development of extensive drug resistance in Multi-Drug resistant tuberculosis patients MSF anti-TB programmes in Abkhazia and Uzbekistan Authors: Cathy.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Country Progress Report Philippines
Country Progress Report VIET NAM
Manila, Dec.2014 NEW DRUGS INTRODUCTION IN VIETNAM – SHORT PROGRESS UPDATE.
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
RNTCP: DOTS Expansion and plans for DOTS-Plus
World Health Organization
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
“World TB day and TB in Mongolia”
JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.
Programmatic Management of Multidrug Resistant TB (PMDT) 5 th Joint International Monitoring Mission of NTP, Thailand 23 August, 2013.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.
June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
DOTS-PLUS IN TANZANIA: PREPARATION PHASE Global DOTS Expansion Working Group Meeting, Paris: 28 October 2004 NTLP - MOH Prepared by: Dr. S. M. Egwaga NTLP.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
Tuberculosis control in Suriname Situational analysis.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
KNCV experience with PV/aDSM Symposium 12 Suzanne Verver, Agnes Gebhard, Susan van den Hof, Gunta Dravniece, Svetlana Pak, Sandra Kik.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
PNG, Philippines and Vietnam. Cascade of Patient Care Action Points All enrolled patients complete their treatment Decentralize services to improve access.
World Health Organization Regional Office for the Western Pacific Drug-resistant tuberculosis in the WHO Western Pacific Region Tauhid Islam Stop TB and.
Current Aspects of TB in Egypt and other EMR countries Dr. Essam Elmoghazy Chairman of Cairo Association against Smoking, Tuberculosis and Lung diseases-
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
A Way out of Directly Observed Therapy (DOT): Community approaches to Self-Administered Treatment for Rifampicin Resistant Tuberculosis in Khayelitsha,
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TB- HIV Collaborative activities in Romania- may 2006 status
NURSES ROLE IN THE CARE AND MANAGEMENT OF MDR-TB
Country Progress Report Cambodia
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
1 Results Background RSBY – What is the Scheme?
TB/HIV surveillance : Who is going to get the job done?
Find and Treat All Missing Persons with TB
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Western Pacific Regional Office
Key issues in DOTS implementation
Richard Laing, Kelly McGoldrick
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Impact of Using Fixed Dose Combinations (FDCs) versus
Background 1  § About 1/3 of world population infected with Tuberculosis (TB) § 25% of all avoidable deaths in developing countries due to TB.
The role of the community in TB control
From TB control to integrated respiratory disease control
National Tuberculosis Control Program in Vietnam
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Fabio Scano IUATLD Conference Paris, 2003
Pharmacy Sector SECTOR COMMITMENT TO END TB
Presentation transcript:

Taipei, June 2016

Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis (TB) situation  Patient centred approach:  The approach recommended by the WHO  Policy and activities implemented in Vietnam  Result and recommendation

Vietnam  Surface km 2  Border: China, Laos, Cambodia  Provinces: 63  Districts: 683  Communes: 11,042  Pop.: 92 milion

Situation of Drug-resistant TB in Viet Nam DRS 3 (06-07)DRS 4 (11-12) MDR rate among new TB patients2.7 % ( %) 4.0 % ( %) MDR rate among retreated patients19% (14-25%) 23.3% ( ) The number of MDR-TB patients among the number of new TB patients every year 2000 ( ) 3000 The number of MDR-TB patients among the number of retreated patients every year 1700 ( ) 2100 Total number of MDR-TB patients among total number of TB patients every year XDR-TB/MDR-TB5.6% FQ res/MDR-TB16.7%

The r esult of 4 th DRS (2011)  Result is similar to Western Pacific countries (WHO report 2012):  New: 4.8% (95% CI: 3.4 – 6.1)  Retreatment: 22% (95% CI: 18 – 26)  Drug resistance has increased so NTP should continue to prioritise:  Scale-up and strengthen Programmatic Management of Drug resistant TB (PMDT)  Improve the detection and enrollment for treatment  Strengthen treatment management, especially when implement 6 month regimen with Rifampicine during entire treatment course to ensure that cured rate is high and the increase of Multi-Drug resistant TB (MDR- TB) is controlled

Patient centred approach recommended by the WHO Rational: Globally, only 50% of MDR-TB patients were successfully treated  50% patients died, failure, lost to follow up or not assessed Poor outcome relates to lack of adherence to treatment due to adverse drug reaction (ADR), inconvenience treatment service, stigma, other psychology-socio-economy (PSE) difficulties  need to address to improve adherence to treatment and treatment outcome Recommendation Patient center approach: establishes collaboration between patient and provider with their rights and responsibilities to achieve treatment success with dignity.  22

Patient centred approach - implemented in Vietnam Policy to implement patient centered approach to : Increase the number of MDR-TB patients enrolled on treatment Improve treatment outcome. Activities under the policy

Patient centred approach implemented in Vietnam-activities Year PMDT provinces Increase accessibility to treatment service: Expansion of PMDT network: More treatment sites and satellite sites  patients not have to travel so far, willing to be enrolled and adhere to treatment More suitable models of care to facilitate patient’s adherence: hospital based care (at TB hospital or general hospital in province without TB hospital available), ambulatory clinic based care (DOT clinic at province, district or communal levels)

Patient centred approach implemented in Vietnam-activities Patient support system to increase adherence to treatment and reduce stigma: Directly observed treatment (DOT) supporters: Oil-slick training model is used for cost saving Provide information to patients and family about TB treatment prior to and during treatment Observation of drugs taken

Patient centred approach implemented in Vietnam-activities Patient support system to increase adherence to treatment and reduce stigma: Directly observed treatment (DOT) supporters: Education of infection control (IC) Recognition of ADR Members involved : health staff, family member, cured MDR-TB patients

Patient centred approach implemented in Vietnam-activities Patient support system to increase adherence to treatment and reduce stigma: PSE supporters Trained on communication skills and psychology of TB patients Give consultation for any psychological difficulties challenged the patients to reduce stigma Currently recruited PSE staff, to be involved by community volunteers in the future

Patient centred approach implemented in Vietnam-activities Patient support system to increase adherence to treatment and reduce stigma: Enable for food and travelling: Global Funds, local charity organization Health insurance system

Patient centred approach implemented in Vietnam-activities Introduction of pharmacovigilence (PV) system to detect and treat adverse drug reaction to improve treatment outcome and reduce lost to follow-up Ancillary drugs for adverse reaction treatment

Pharmacovigilance National DI & ADR center Southern center Provincial/Dist rict/Private hospital, health centers Middle center Provincial/Dist rict/Private hospital, health centers Northern center Provincial/Dist rict/Private hospital, health centers National Health Programs (HIV/AIDS, TB, Malaria...) specialized provincial/district treatment sites

PV methods in NTP Spontaneous reporting Cohort Event Monitoring(aDSM) Since 2006 Since 2012

Patient centred approach implemented in Vietnam-activities Establish the collaboration between PMDT and non-PMDT service: For referring MDR-TB presumptives from non PMDT-PMDT service to increase MDR-TB diagnosis To provide quality of treatment service to MDR- TB patients (general hospital) by training, facility upgrade Mechanism to refer patients between two sectors based on patient’s need to ensure the continuation of treatment :

Patient centred approach implemented in Vietnam-activities Pilot a strategy (FAST)that contribute to shorten time from notification to treatment and ensure effective treatment: FAST is a strategy consists of components: Finding TB and MDR TB cases Actively, Separating safely, Treating effectively Measuring times as important process indicators Time from cough detection to sputum collection Time from sputum collection to lab Time from lab to result Time from result to notification Time from notification to treatment Adaptation to different settings ( criteria, protocol, Algorithm for diagnosis and treatment initiation, Monitoring,Recording/ reporting,Supervision and evaluation)

Results The number of MDR-TB patients enrolled for treatment increased over the years Enrollment Total The number of enrolled patients % of enrollment3% 16%19%25%30%42%

Results The treatment success rate for MDR-TB in Vietnam has been stable at around 70%, which is higher than global level YearcuredCom.DiedFailled Loss to f.up Not acessedSuccess %11%8%7%9%3%73% %6%8%7%6%0%78% %11%7% 13%1%72% %15%10%6%12%3%70% %16%9%7%14%1%69%

Conclusion and recommendation The increased number of patients enrolled for treatment and the favorable success rate achieved may reflect a promising Patient-Centred Care adopted by PMDT of Vietnam. However: So far a significant number of patients diagnosed but not enrolled for treatment (5-10%) Unfavorable treatment outcome: died (7-8%), failure (7%), lost to follow up (7-10%, increase when expansion, higher among patient treated outside PMDT)  Vietnam need to continue improve treatment enrollment and treatment outcome using patient centered care approach.

21